 Connection
Matthew Daley to Papillomavirus Infections
This is a "connection" page, showing publications Matthew Daley has written about Papillomavirus Infections.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.178 |
|
|
|
-
Newcomer SR, Caringi J, Jones B, Coyle E, Schehl T, Daley MF. A Mixed-Methods Analysis of Barriers to and Facilitators of Human Papillomavirus Vaccination Among Adolescents in Montana. Public Health Rep. 2020 Nov/Dec; 135(6):842-850.
Score: 0.476
-
Kempe A, Allison MA, Daley MF. Can School-Located Vaccination Have a Major Impact on Human Papillomavirus Vaccination Rates in the United States? Acad Pediatr. 2018 03; 18(2S):S101-S105.
Score: 0.398
-
Kempe A, O'Leary ST, Shoup JA, Stokley S, Lockhart S, Furniss A, Dickinson LM, Barnard J, Daley MF. Parental Choice of Recall Method for HPV Vaccination: A Pragmatic Trial. Pediatrics. 2016 Mar; 137(3):e20152857.
Score: 0.346
-
Roblin DW, Ritzwoller DP, Rees DI, Carroll NM, Chang A, Daley MF. The influence of deductible health plans on receipt of the human papillomavirus vaccine series. J Adolesc Health. 2014 Mar; 54(3):275-81.
Score: 0.302
-
Daley MF, Liddon N, Crane LA, Beaty BL, Barrow J, Babbel C, Markowitz LE, Dunne EF, Stokley S, Dickinson LM, Berman S, Kempe A. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics. 2006 Dec; 118(6):2280-9.
Score: 0.183
-
Sundaram ME, Kieke BA, Hanson KE, Belongia EA, Weintraub ES, Daley MF, Hechter RC, Klein NP, Lewis EM, Naleway AL, Nelson JC, Donahue JG. Extended surveillance to assess safety of 9-valent human papillomavirus vaccine. Hum Vaccin Immunother. 2022 12 30; 18(7):2159215.
Score: 0.139
-
Donahue JG, Kieke BA, Lewis EM, Weintraub ES, Hanson KE, McClure DL, Vickers ER, Gee J, Daley MF, DeStefano F, Hechter RC, Jackson LA, Klein NP, Naleway AL, Nelson JC, Belongia EA. Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine. Pediatrics. 2019 12; 144(6).
Score: 0.112
-
Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Sheth SS, Zhu J, Naleway AL, Klein NP, Hechter R, Daley MF, Donahue JG, Jackson ML, Kawai AT, Sukumaran L, Nordin JD. Risk of Spontaneous Abortion After Inadvertent Human Papillomavirus Vaccination in Pregnancy. Obstet Gynecol. 2018 07; 132(1):35-44.
Score: 0.102
-
Hariri S, Schuler MS, Naleway AL, Daley MF, Weinmann S, Crane B, Newcomer SR, Tolsma D, Markowitz LE. Human Papillomavirus Vaccine Effectiveness Against Incident Genital Warts Among Female Health-Plan Enrollees, United States. Am J Epidemiol. 2018 02 01; 187(2):298-305.
Score: 0.099
-
Naleway AL, Crane B, Smith N, Daley MF, Donahue J, Gee J, Greene SK, Harrington T, Jackson LA, Klein NP, Tseng HF, Vellozzi C, Weintraub ES. Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011. Vaccine. 2016 Jan 02; 34(1):167-71.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|